Macleods Pharma recalls products in US on account of manufacturing issues
According to the US health regulator, the New Jersey-based Macleods Pharma USA is recalling the affected lot due to "eCGMP (current good manufacturing practices) deviations".
New Delhi: Macleods Pharmaceuticals is recalling two products in the US market due to deviation from standard manufacturing norms, according to a USFDA report. According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of the drug firm is recalling 3,672 bottles of Amlodipine and Olmesartan Medoxomil tablets, used to treat high...
New Delhi: Macleods Pharmaceuticals is recalling two products in the US market due to deviation from standard manufacturing norms, according to a USFDA report. According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of the drug firm is recalling 3,672 bottles of Amlodipine and Olmesartan Medoxomil tablets, used to treat high blood pressure.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd